Gentex
GNTXNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $19.42 Prior regular-session close from the quote source.
- $19.24–$19.58 Regular-session low and high so far today.
- 2.5M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Jan 29 projected Projected for 2027-01-29 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $19.24–$26.48 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own GNTX if its entrenched automotive electronics franchise keeps winning vehicle content at attractive margins, not merely if auto production volumes recover.
GNTX price history
Loading recent earnings…
Investment thesis
What must happen next
Gentex’s OEM platform position and rising vehicle electronic content continue to convert into higher sales even when underlying auto production is uneven.StrengtheningMateriality: High
GAAP annual revenue rose to $2.534 billion in FY2025 from $2.313 billion in FY2024. If this holds, Gentex can grow beyond the auto production cycle; if it breaks, the company becomes a lower-growth cyclical supplier.
Watch: Major OEMs award next-generation mirror, display, or visibility-system programs to Magna, Murakami, Valeo, Samvardhana Motherson, or other competing suppliers.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual revenue rose to $2.534 billion in FY2025 from $2.313 billion in FY2024.
Open source ↗Gentex’s manufacturing process control and product differentiation allow it to withstand normal OEM price-downs and input-cost volatility at the gross-margin line.StrengtheningMateriality: High
GAAP annual gross profit increased to $866.7 million in FY2025 from $771.1 million in FY2024. Gross margin is where supplier pricing power and manufacturing advantage show up first; erosion would signal that growth is being bought too cheaply.
Watch: OEMs force larger annual price concessions on new programs or rebids, especially if competing suppliers offer lower-cost alternatives.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual gross profit increased to $866.7 million in FY2025 from $771.1 million in FY2024.
Open source ↗Gentex’s newer content and engineering investments must scale without absorbing the benefits of revenue growth; recent results show this driver is not yet clearly proven.HoldingMateriality: Medium
GAAP annual operating income was $473.9 million in FY2025, up modestly from $459.7 million in FY2024. The stock’s long-term value depends on incremental sales becoming incremental operating profit, not only on larger revenue.
Watch: New product programs require sustained engineering, software, tooling, or warranty spending that prevents operating leverage.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating income was $473.9 million in FY2025, up modestly from $459.7 million in FY2024.
Open source ↗Gentex’s installed OEM programs and working-capital discipline keep converting accounting profit into cash that can fund reinvestment and owner returns through the cycle.StrengtheningMateriality: Medium
GAAP annual operating cash flow was $587.1 million in FY2025, above GAAP net income of $384.8 million. Strong cash conversion gives holders downside resilience and funds product investment without relying on leverage.
Watch: Large new-program launches require inventory, tooling, or receivables investment that structurally reduces cash conversion.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating cash flow was $587.1 million in FY2025, above GAAP net income of $384.8 million.
Open source ↗Gentex must restore profit conversion or more effective capital allocation for revenue growth to become per-share compounding, because recent sales gains have not translated into higher diluted EPS.WeakeningMateriality: Medium
GAAP diluted EPS was $1.74 in FY2025, down from $1.76 in FY2024 and $1.84 in FY2023. Owners are paid in per-share value; if EPS stagnates while revenue rises, the multiple should compress or stay capped.
Watch: Operating-margin pressure persists because new content carries lower margins than legacy programs.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP diluted EPS was $1.74 in FY2025, down from $1.76 in FY2024 and $1.84 in FY2023.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Gentex’s OEM platform position and rising vehicle electronic content continue to convert into higher sales even when underlying auto production is uneven. If this holds, Gentex can grow beyond the auto production cycle; if it breaks, the company becomes a lower-growth cyclical supplier.
Gentex’s manufacturing process control and product differentiation allow it to withstand normal OEM price-downs and input-cost volatility at the gross-margin line. Gross margin is where supplier pricing power and manufacturing advantage show up first; erosion would signal that growth is being bought too cheaply.
Gentex’s newer content and engineering investments must scale without absorbing the benefits of revenue growth; recent results show this driver is not yet clearly proven. The stock’s long-term value depends on incremental sales becoming incremental operating profit, not only on larger revenue.
Gentex’s installed OEM programs and working-capital discipline keep converting accounting profit into cash that can fund reinvestment and owner returns through the cycle. Strong cash conversion gives holders downside resilience and funds product investment without relying on leverage.
Gentex must restore profit conversion or more effective capital allocation for revenue growth to become per-share compounding, because recent sales gains have not translated into higher diluted EPS. Owners are paid in per-share value; if EPS stagnates while revenue rises, the multiple should compress or stay capped.
All standing thesis claims
Original report summary
its entrenched automotive electronics franchise keeps winning vehicle content at attractive margins, not merely if auto production volumes recover.
Bull case and bear case
Bull case and bear case for Gentex
Where the evidence on Gentex disagrees: Mixed on the latest evidence (Oct 23, 2026). Of its 5 thesis points, 3 strengthening, 1 holding and 1 weakening.
Bull case: what the evidence supports
Gentex’s OEM platform position and rising vehicle electronic content continue to convert into higher sales even when underlying auto production is uneven.
Gentex’s manufacturing process control and product differentiation allow it to withstand normal OEM price-downs and input-cost volatility at the gross-margin line.
Gentex’s newer content and engineering investments must scale without absorbing the benefits of revenue growth; recent results show this driver is not yet clearly proven.
Gentex’s installed OEM programs and working-capital discipline keep converting accounting profit into cash that can fund reinvestment and owner returns through the cycle.
Bear case: what the evidence questions
Gentex must restore profit conversion or more effective capital allocation for revenue growth to become per-share compounding, because recent sales gains have not translated into higher diluted EPS.
Thesis-Break Engine
What has broken in Gentex’s thesis
Each break OptimistFi flagged on Gentex, dated — with what has historically followed the same kind of break across the market, not a forecast for Gentex.
- Analyst downgradecondition set before this filing
Across all companies, this kind of break has happened 12,641 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Gentex filed an SEC 8-K on 2026-10-23: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Gentex filed an SEC 8-K on 2026-07-24: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Gentex filed an SEC 8-K on 2026-04-24: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Major OEMs award next-generation mirror, display, or visibility-system programs to Magna, Murakami, Valeo, Samvardhana Motherson, or other competing suppliers.
- OEMs force larger annual price concessions on new programs or rebids, especially if competing suppliers offer lower-cost alternatives.
- New product programs require sustained engineering, software, tooling, or warranty spending that prevents operating leverage.
- Large new-program launches require inventory, tooling, or receivables investment that structurally reduces cash conversion.
- Operating-margin pressure persists because new content carries lower margins than legacy programs.
GNTX news
Loading headlines…
Financial statements
GNTX income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
GNTX: quick answers
- When does Gentex (GNTX) report earnings next?
- Gentex's next results are projected for January 29, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 23, 2026. Earnings calendar
- What is GNTX's short interest?
- As of October 30, 2026, 18.8M GNTX shares were sold short, 9.16% of its shares outstanding, down 0.7% from the count before. At the stock's average daily volume that is 5.1 days to cover. FINRA publishes the count twice a month. GNTX short interest history
- Have members of Congress traded GNTX?
- 9 trades in GNTX have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed GNTX trade
- Which well-known investors own GNTX?
- 1 of the 37 well-known funds tracked here reported GNTX shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios
GNTX in well-known investors’ portfolios
1 of 37 funds reported GNTX shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Ray DalioBridgewater Associates | 0.01% | $1.8M | +497.7% | Q2 2026 |
